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a b s t r a c t
Endothelial cells are believed to play an important role in response to virus infection. Here, we used a
microarray technology to study the gene expression proﬁle in human umbilical vein endothelial cells at
24 h postinfection with H9N2 viruses or inactivated H9N2 viral particles. The results showed that H9N2
virus infection induced an abundance of differential expressed genes, exhibiting a transcriptional
signature of viral infection. High levels of chemokine gene expressions were detected following
treatment. Surprisingly, the most signiﬁcantly up-regulated genes were mainly interferon-stimulated
genes (ISGs), although there was no change in interferon gene expression and interferon protein level.
We also found that viral particles were more potent than viruses in inducing ISGs expression. These
results suggest that induction of expression of ISGs is mainly dependent on the interaction between viral
particles and endothelial cells. Our data offer further insight into the interaction between endothelial
cells and H9N2 inﬂuenza viruses.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Avian H9N2 inﬂuenza viruses are known to circulate in poultry of
counties in Asia, Middle East, Europe and Africa (Aamir et al., 2007;
Alexander, 2007; Li et al., 2005) and pose a potential threat to human
due to their ability to infect mammals including human (Butt et al.,
2005; Choi et al., 2004). It is noteworthy that H9N2 viruses have been
isolated from pigs and humans in China since 1998 (Guo et al., 1999;
Lin et al., 2000; Peiris et al., 2001, 1999), indicating that H9N2 viruses
have crossed species barriers and expand their hosts from birds to
mammals. Contemporary H9N2 viruses and pandemic H1N1 viruses
have high genetic compatibility and can generate reassortants with
higher pathogenicity in experimental conditions (Sun et al., 2011).
Recent studies have also shown that H9N2 viruses are likely to
contribute to the evolution of the H7N9 viruses that cause severe
human respiratory infections in China (Yu et al., 2014). It is imperative
to understand the host immune responses to H9N2 viruses in the
light of the potential threat of H9N2 viruses.
In general, human inﬂuenza viruses and avian inﬂuenza viruses
prefer to bind to a group of cells expressing sialic acid with α-2, 6-
and α-2, 3-linked sialic acids receptors, respectively (Connor et al.,
1994). Both receptor types were detected in respiratory tract (Nicholls
et al., 2007), leading to the identiﬁcation of airway epithelial cells as
the main target of inﬂuenza virus infection (Ibricevic et al., 2006).
Most of endothelial cells expressed both types of receptors, which
may account for the multiple organ involvement in inﬂuenza infec-
tion (Yao et al., 2008). Teijaro et al. (2011) revealed that endothelial
cells might be the source of the cytokines and involved in the
pathogenesis during inﬂuenza virus infection. Recent study indicates
that the endothelial cells infected with H5N1 inﬂuenza viruses may
initiate innate immune response of the host by activating type I
interferon (IFN) response (Viemann et al., 2011). So, it is important to
understand the cellular responses in endothelial cell during inﬂuenza
virus infection. Little is known about the responses of host endothelial
cells to H9N2 virus infection. The present study aimed (1) to
investigate whether endothelial cells support the productive replica-
tion of H9N2 inﬂuenza virus; (2) to investigate the endothelial cell
responses to H9N2 virus infection, by microarray analysis of the
global patterns of gene expression of human umbilical vein endothe-
lial cells (HUVECs) inoculated with H9N2 viruses or inactivated H9N2
viral particles. Our data will offer further insight into the interaction
between endothelial cells and H9N2 inﬂuenza viruses.
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Results
Infection and replication of H9N2 virus in HUVECs
To establish whether HUVECs support H9N2 virus infection, the
titers of viruses in the supernatant of HUVECs were measured by
PFUs. First, the replication of H9N2 viruses with different MOI was
observed in HUVECs grown in 6-well plates. When HUVECs were
treated with H9N2 viruses at different MOI for 24 h, viral infection
caused a dose-dependent increment in titer levels, as shown in
Fig. 1A. With a MOI of 5 or 10, virus titers reached of
5.67104 PFU/mL and 1.57105 PFU/mL, respectively (Fig. 1A).
Subsequently, the kinetics of replication of H9N2 viruses was
investigated at several time points postinfection at MOI of 5 and
0.2, respectively, as shown in Fig. 1B. At a MOI of 5, the productive
replication of H9N2 viruses was detected at 6 h postinfection and
reached peak titers of 7.67104 PFU/mL at 36 h postinfection. At a
MOI of 0.2, virus titers were observed at 36 h postinfection and
reached peak of 3.30104 PFU/mL at 48 h postinfection. Finally,
the difference of viral growth kinetics at a MOI of 0.2 was
compared between HUVECs and MDCK cells. MDCK cell is a
standard model cell for inﬂuenza virus infection. As shown in
Fig. 2, although the yields of the H9N2 viruses were signiﬁcantly
higher (P valueo0.01, t-test) in MDCK cells than those in HUVECs,
viruses showed the similar growth kinetic characteristics in both
cell types. Our data showed that HUVECs supported the productive
replication of H9N2 virus in the presence of trypsin.
The condition for microassay experiments was chosen at a virus
MOI of 5 and 24 h, based on the following results. Released viruses
were detected at 6 h postinfection and peaked at 36 h postinfec-
tion. So, 24 h time point represented the active stage of infection
with increased viral titer. At this time point, we postulated that
cell state would largely represent the steady gene expression
changes. In addition, when HUVECs were infected with H9N2
viruses at a MOI of 5, we could obtain a good replication kinetic
pattern of the viruses (Fig. 1B).
Cell viability assay
To determine the effect of H9N2 virus on cell death, HUVECs
were infected with the viruses at a MOI of 5, and cell viability was
determined at selected time intervals by the trypan blue-exclusion
assay. At 24 h postinfection, there were approximately 62% viable
cells, which decreased to 43% at 36 h postinfection (Fig. 3). For
mock-infected cells, the number of viable cells remained relatively
Fig. 1. Replication of H9N2 viruses in human umbilical vein endothelial cells (HUVECs). HUVECs grown on six-well plates were infected with H9N2 virus at different
multiplicity of infection (MOI). Culture supernatants were collected at a given time, and viral titers were determined by plaque-forming units. Values represent the means
from three independent experiments plus standard deviations. (A) Replication of H9N2 viruses at 24 h postinfection with different MOI. (B) Replication of H9N2 viruses at
different time points after infection with MOI of 5 and 0.2, respectively. **, H9N2 virus at a MOI of 5 replicates to a signiﬁcantly higher titer than H9N2 virus at a MOI of 0.2 (P
valueo0.01, t-test).
Fig. 2. Replication of H9N2 inﬂuenza viruses in human umbilical vein endothelial
cells (HUVECs) and Madin–Darby canine kidney (MDCK) cells. HUVECs and MDCK
cells were infected with H9N2 virus at a multiplicity of infection (MOI) of 0.2 for
72 h, respectively. Culture supernatants were collected and viral titers were
determined by plaque-forming units. Values represent the means from three
independent experiments plus standard deviations. **, the value of corresponding
virus was signiﬁcantly between cells (P valueo0.01, t-test).
Fig. 3. Effects of H9N2 virus infection on viability of human umbilical vein
endothelial cells (HUVECs). HUVECs were infected with H9N2 viruses at a multi-
plicity of infection (MOI) of 5. The percentage viability of the HUVEC was carried
out by using the trypan blue dye exclusion method. Values represent the means
from three independent experiments plus standard deviations.
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constant throughout the experiment. Our data demonstrated that
H9N2 viral infection caused an apparent decrease in viability of
HUVECs. This drop in cell viability might be related with reduction
in viral titers at the late stage of H9N2 virus infection of HUVECs.
Overview of microarray data
Considering the biological difference between H9N2 viral
infection and viral particle treatment, we inoculated HUVECs with
H9N2 viruses and inactivated viral particles, respectively, and
observed the global patterns of gene expression using microarray
technology at 24 h after inoculation. Microarray analysis showed
that H9N2 virus infection induced an abundance of DEGs when
compared to its control, exhibiting a transcriptional signature of
viral infection. H9N2 virus infection induced 6300 of DEGs (2.0
folds up/down-regulation and P valueo0.05). Of these DEGs, 2091
were up-regulated and 4209 were down-regulated. In a striking
contrast, inoculation with H9N2 viral particles yielded a much
smaller numbers of DEGs (263 DEGs, 177 up-regulated genes and
86 down-regulated genes), indicating a non-infectious transcrip-
tional signature. Fig. 4A clearly showed the huge difference in the
number of DEGs between H9N2 virus infection and viral particle
treatment. Then, gene expression data were compared between
the two treatment groups. A total of 144 DEGs were induced by the
two groups (Fig. 4B), whereas 6156 DEGs were speciﬁcally induced
by H9N2 virus infection. Functional clustering according to gene
ontology annotations revealed that DEGs induced by the two
groups primarily belonged to immune response and chemotaxis.
H9N2-speciﬁc DEGs had functions assigned to cell biological
process (including cell cycle and transcription). Supplementary
Table 1 listed 50 most up- or down-regulated DEGs in H9N2 viral
particle-inoculated HUVECs and 100 most up- or down-regulated
DEGs in H9N2 virus-infected HUVECs.
To compare the similarities and differences between H9N2
virus and viral particles responsive genes, 6442 genes were
selected that exhibited at least a 2-fold difference in abundance
in either in H9N2 virus group or in viral particle group. Then, data
were log transformed with base 2 and hierarchically clustered
using Gene Cluster 3.0 software based on the average linkage
distance measure. Genes selected for this analysis fell into three
broad clusters (Fig. 5). The main GO biological processes and KEGG
pathways represented in these three clusters will be described
below and showed in Supplementary Table 2.
Cluster 1 contains 129 genes. In this cluster, all the genes
induced by H9N2 viral particles showed a signiﬁcant up-regulation
higher than the corresponding genes in response to H9N2 viruses.
Most of DEGs in this cluster were interferon-stimulated genes
(ISGs). GO analysis suggested that the biological processes most
enriched in this cluster are related to response to virus, immune
response and defense response. KEGG analysis showed that the
signaling pathways are mainly associated with the antigen proces-
sing and presentation and the RIG-I-like receptor signaling. Since
the most signiﬁcantly up-regulated genes related to virus-host
response fell into cluster 1, we expanded the gene display of
cluster 1 on the right in Fig. 5.
Cluster 2 contains 2063 genes. In this cluster, all the genes
induced by H9N2 virus infection showed a signiﬁcant up-regula-
tion, whereas almost none of these genes (except for chemokine
genes) showed signiﬁcant changes in response to viral particles.
The most up-regulated genes in this cluster were those encoding
chemokines (including CCL5, CXCL10 and CXCL11). The other up-
regulated genes in response to H9N2 virus were mainly involved
in viral replication as indicated by GO function and KEGG pathway
analysis (Supplementary Table 2), which is consistent with our
result that H9N2 viruses replicated efﬁciently in endothelial cells
at 24 h after inoculation. With further dissection of biological
processes of DEGs induced by H9N2 virus infection, we found that
some up-regulated genes in this cluster were associated with cell
apoptosis (Table 1).
Cluster 3 contains 4250 genes. In this cluster, almost all of
genes were down-regulated by H9N2 virus infection, but showed
no signiﬁcant changes in transcriptional activity in response to
viral particles. GO function and KEGG pathway analysis indicated
that the down-regulated DEGs in response to viral infection were
mainly involved in cell biological process (including cell cycle and
transcription), which is in accordance with a global transcriptional
shut-off of host cell due to virus replication.
Selected gene expression proﬁles
The interaction between endothelial cells and inﬂuenza viruses
may contribute to the development of severe inﬂuenza disease of
animals and human (Armstrong et al., 2013). The changes in gene
expression observed with microarray technology provide some
important data. In the present study, we mainly focused on three
aspects of gene transcriptional change. These genes include the
genes associated with the structure and function of endothelial
Fig. 4. The differentially expressed genes (DEGs) in human umbilical vein endothelial cells (HUVECs) at 24 h after inoculation with H9N2 viruses and inactivated viral
particles. HUVECs were inoculated with H9N2 viruses (i.e., Virus) and inactivated H9N2 viral particles (i.e., Particle) at a multiplicity of infection (MOI) of 5, respectively. After
24 h postinfection, the number of DEGs in HUVECs was counted. In a comparison analysis between experiment and control groups, the genes with 2.0 folds up/down-
regulation and P valueo0.05 (Student's t-test) were considered as DEGs. (A) Stacked bar chart shows the number of DEGs. (B) Venn diagram shows the number and overlap
of DEGs.
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cell itself, the IFN genes and ISGs and the genes encoding pro-
inﬂammatory cytokines and chemokines.
Expression changes of the genes encoding proteins associated
with the structure and function of endothelial cell itself: these
genes include apoptosis-related genes, adhesion molecule genes
and tight junction protein genes. Apoptosis in general is consid-
ered as a host strategy to limit the virus replication (Everett and
McFadden, 1999). GO function analysis revealed 317 DEGs enric-
hed in regulation of apoptosis in HUVECs after H9N2 virus infec-
tion, and that viral particles did not signiﬁcantly affect the expr-
ession of apoptosis-related genes in transcriptional activity. These
data suggest that H9N2 virus infection may have a profound effect
on endothelial cell survival. Table 1 shows the selected apoptosis-
related genes that exhibited at least a 5-fold difference (up and
down) in abundance. Cytochrome c-mediated apoptosis pathway
is well established. We noticed that CYCS (cytochrome c, somatic)
gene exhibited 10-fold up-regulation in H9N2 virus-infected
HUVECs. Adhesion molecules expressed by activated endothe-
lium mediate leukocyte adhesion and transendothelial migration
(Zhang et al., 2011). As shown in Table 1, H9N2 virus infection
induced the differential expression of some adhesion molecule
genes. ICAM1 gene was signiﬁcantly down-regulated and the
Fig. 5. Clustering analysis of differentially expressed genes (DEGs) in human umbilical vein endothelial cells (HUVECs) at 24 h after inoculation with H9N2 virus and
inactivated viral particle. To detect gene groupings that manifest similar expression patterns between H9N2 virus and viral particle, 6445 DEGs were hierarchically clustered
based on the average linkage distance measure using Gene Cluster 3.0 and visualized the gene expression cluster with Java Tree View. Gene expression levels were
represented by a color key, with red for up-regulated, green for down-regulated, and black for no change. Cluster columns from left to right: control (control group), particle
(inactivated viral particle-inoculation group) and virus (H9N2 virus-infection group). Three separate clusters were indicated by bars and by identiﬁcation of the
corresponding region of the dendrogram. Cluster 1 was shown enlarged with the gene annotation given on the right side.
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Table 1
Expression changes of selected genes in human umbilical vein endothelial cells inoculated with H9N2 viruses or inactivated H9N2 viral particles.
Probe set ID Gene description Gene symbol Fold change
Virus Particle
Apoptosis-related genes
204995_at Cyclin-dependent kinase 5, regulatory subunit 1 (p35) CDK5R1 35.81nn 0.79
206197_at NME/NM23 family member 5 NME5 34.13nn 0.95
236449_at Cystatin B (steﬁn B) CSTB 27.79nn 0.87
242214_at Ribosomal protein S27a RPS27A 26.20nn 1.02
209318_x_at Pleiomorphic adenoma gene-like 1 PLAGL1 23.96n 1.09
204891_s_at Lymphocyte-speciﬁc protein tyrosine kinase LCK 22.10n 1.01
213492_at Collagen, type II, alpha 1 COL2A1 17.72nn 0.97
206727_at Complement component 9 C9 15.02n 1.07
1559754_at Lymphotoxin beta (TNF superfamily, member 3) LTB 10.98nn 0.89
244546_at Cytochrome c, somatic CYCS 10.66nn 0.64
214575_s_at Azurocidin 1 AZU1 9.32nn 0.99
204286_s_at Phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 9.04nn 1.93
210639_s_at Autophagy related 5 ATG5 0.19nn 1.02
224217_s_at Fas (TNFRSF6) associated factor 1 FAF1 0.15n 1.04
202535_at Fas (TNFRSF6)-associated via death domain FADD 0.15n 1.23
235427_at CASP8 and FADD-like apoptosis regulator CFLAR 0.15 0.66
221566_s_at Nucleolar protein 3 (apoptosis repressor with CARD domain) NOL3 0.15n 1.02
205780_at BCL2-interacting killer (apoptosis-inducing) BIK 0.13n 1.11
203139_at Death-associated protein kinase 1 DAPK1 0.09n 0.88
203120_at Tumor protein p53 binding protein, 2 TP53BP2 0.09nn 1.05
226231_at PRKC, apoptosis, WT1, regulator PAWR 0.07 0.76
215719_x_at Fas (TNF receptor superfamily, member 6) FAS 0.06nn 1.07
210026_s_at Caspase recruitment domain family, member 10 CARD10 0.05n 0.91
202677_at RAS p21 protein activator (GTPase activating protein) 1 RASA1 0.04n 0.89
200636_s_at Protein tyrosine phosphatase, receptor type, F PTPRF 0.04n 0.63
226213_at v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) ERBB3 0.03n 0.81
203935_at Activin A receptor, type I ACVR1 0.03nn 0.94
Adhesion molecule genes
202637_s_at Intercellular adhesion molecule 1 ICAM1 0.23nn 1.19
204683_at Intercellular adhesion molecule 2 ICAM2 1.20 1.19
204949_at Intercellular adhesion molecule 3 ICAM3 0.68 0.92
207194_s_at Intercellular adhesion molecule 4 ICAM4 71.47nn 1.04
203868_s_at Vascular cell adhesion molecule 1 VCAM1 1.17 0.75
206211_at Selectin E SELE 4.95 1.04
Tight junction-related genes
209925_at Occludin OCLN 0.14n 0.94
222549_at Claudin 1 CLDN1 0.06n 0.88
204482_at Claudin 5 CLDN5 1.54 0.86
228335_at Claudin 11 CLDN11 0.04nn 0.67
1552535_at Claudin 19 CLDN19 2.32n 1.06
228707_at Claudin 23 CLDN23 0.46n 1.58
229127_at Junctional adhesion molecule 2 JAM2 0.78 0.60
212813_at Junctional adhesion molecule 3 JAM3 1.33 0.97
Proinﬂammatory cytokine genes
208200_at Interleukin 1, alpha IL1A 1.14 1.11
39402_at Interleukin 1, beta IL1B 0.79 1.10
205207_at Interleukin 6 (interferon, beta 2) IL6 0.85 1.04
211506_s_at Interleukin 8 IL8 0.63 0.92
207433_at Interleukin 10 IL10 1.14 0.85
206295_at Interleukin 18 IL18 0.20 0.83
207113_s_at Tumor necrosis factor TNF 1.95 0.84
Chemokine genes
207533_at Chemokine (C-C motif) ligand 1 CCL1 1.11 1.04
216598_s_at Chemokine (C-C motif) ligand 2 CCL2 1.76nn 0.33
205114_s_at Chemokine (C-C motif) ligand 3 CCL3 1.47 1.00
204103_at Chemokine (C-C motif) ligand 4 CCL4 2.90n 0.88
1405_i_at Chemokine (C-C motif) ligand 5 CCL5 159.42n 20.22
203915_at Chemokine (C-C motif) ligand 9 CXCL9 3.91nn 1.05
204533_at Chemokine (C-X-C motif) ligand 10 CXCL10 127.75n 49.33
211122_s_at Chemokine (C-X-C motif) ligand 11 CXCL11 93.26 40.68
Interferon genes
208375_at Interferon, alpha 1 IFNA1 1.06 1.11
211338_at Interferon, alpha 2 IFNA2 1.40 1.09
207964_x_at Interferon, alpha 4 IFNA4 1.81 0.87
208173_at Interferon, beta 1, ﬁbroblast IFNB1 1.98 1.89
210354_at Interferon, gamma IFNG 1.35 1.11
Interferon-stimulated genes (ISGs)
204415_at Interferon, alpha-inducible protein 6 IFI6 11.10n 32.09
208966_x_at Interferon, gamma-inducible protein 16 IFI16 2.13nn 6.19
202411_at Interferon, alpha-inducible protein 27 IFI27 83.78n 129.92
214453_s_at Interferon-induced protein 44 IFI44 26.03n 77.68
204439_at Interferon-induced protein 44-like IFI44L 137.57 189.58
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genes encoding ICAM4 and SELE were signiﬁcantly up-regulated.
Alterations in tight junction proteins may lead to the endothelial
leak (Armstrong et al., 2012). Our data showed that inﬂuenza virus
infection signiﬁcantly down-regulated the expression of genes
encoding tight junction proteins (OCLN, CLDN1, CLDN11 and
CLDN23) in transcriptional activity.
Expression changes of the proinﬂammatory cytokine genes and
chemokine genes: the recruitment of innate immune cells into the
lungs combined with excessive proinﬂammatory cytokine and
chemokine production are hallmarks of inﬂuenza virus infection
(La Gruta et al., 2007). We did not ﬁnd signiﬁcant changes in
proinﬂammatory cytokine gene expression (including TNF, IL1A,
IL1B, IL6 and IL10) at 24 h after inoculation with H9N2 virus and
viral particles (Table 1). Chemokines are involved in the recruit-
ment of circulating leukocytes into the inﬂamed tissues (Struyf
et al., 2005). Microarray analysis showed that HUVECs expressed
high levels of the chemokine genes (including CCL5, CXCL10 and
CXCL11) in transcriptional activity at 24 h after inoculation with
H9N2 viruses and viral particles (Table 1). In the meanwhile, H9N2
virus infection induced more signiﬁcant up-regulation of chemo-
kine genes in HUVECs compared with viral particle inoculation.
These data indicated that both H9N2 viral particle itself and viral
replication in endothelial cells led to the transcriptional expres-
sions of chemokine genes.
Expression changes of the interferon (IFN) genes and inter-
feron-stimulated genes (ISGs): it is believed that production of
type I IFN is the key response to many viral infections, leading to
the transcription of various ISGs, some of which encode direct
antiviral effectors (Schoggins and Rice, 2011). It is not known
whether H9N2 viruses or viral particles affect the transcriptional
expression of IFNs. In this study, IFN gene expression induced by
H9N2 viruses and viral particles showed no signiﬁcant change in
transcriptional activity at 24 h postinfection (Table 1). Surprisingly,
microarray data showed that the most signiﬁcantly up-regulated
genes were ISGs in HUVECs at 24 h after inoculation with H9N2
virus and viral particles (Table 1), although no change of IFN gene
expression was found. Among these highly up-regulated ISGs were
the genes encoding interferon alpha-inducible protein (IFI6 and
IFI27), interferon inducible protein 44 (IFI44), interferon-induced
protein 44-like (IFI44L) and interferon gamma-inducible protein
16 (IFI16), the genes encoding interferon-induced protein with
tetratricopeptide repeats (IFIT), including IFIT1, IFIT2, IFIT3 and
IFIT5, the genes encoding interferon-induced transmembrane
(IFITM) proteins (IFITM1 and IFITM2) and the genes encoding 20-
50oligoadenylate synthetase (OAS) protein (OAS1 and OAS2). In
addition, we found that inactivated H9N2 viral particles were
more potent than H9N2 viruses in inducing ISGs expressions in
transcriptional activity.
IFN-α/β levels in HUVECs
For validation of IFN expression change at protein level, we
quantiﬁed the IFN-α/β in response to H9N2 virus and viral
particles using human IFN-α and IFN-β ELISA Kits. HUVECs were
inoculated with H9N2 virus or viral particles at a MOI of 5, and
then supernatants were collected at 6, 12, 24 and 36 h postinfec-
tion for ELISA assays (Fig. 6). The results showed that there were
no signiﬁcant differences (P value40.05, ANOVA) in released IFN-
Table 1 (continued )
Probe set ID Gene description Gene symbol Fold change
Virus Particle
203153_at Interferon-induced protein with tetratricopeptide repeats 1 IFIT1 34.24nn 125.29
226757_at Interferon-induced protein with tetratricopeptide repeats 2 IFIT2 15.86 27.45
204747_at Interferon-induced protein with tetratricopeptide repeats 3 IFIT3 17.14 22.30
203595_s_at Interferon-induced protein with tetratricopeptide repeats 5 IFIT5 3.25n 4.81
214022_s_at Interferon induced transmembrane protein 1 IFITM1 8.53n 44.75
201601_x_at Interferon induced transmembrane protein 2 IFITM2 3.18n 20.50
202869_at 20-50-oligoadenylate synthetase 1, 40/46 kDa OAS1 11.99 44.33
204972_at 20-50-oligoadenylate synthetase 2, 69/71 kDa OAS2 12.86nn 57.62
We inoculated human umbilical vein endothelial cells with H9N2 viruses (i.e., Virus) and inactivated H9N2 viral particles (i.e., Particle) at a
multiplicity of infection (MOI) of 5, respectively, and then used microarrays to observe the change of gene expression at 24 h after inoculation.
Signiﬁcant up-regulation was in bold and signiﬁcant down-regulation was underlined.
n Compared with inactivated H9N2 viral particles (i.e., Particle) group (P valueo0.05, t-test).
nn Compared with inactivated H9N2 viral particles (i.e., Particle) group (P valueo0.01, t-test).
Fig. 6. Evaluation of interferon (IFN) production in human umbilical vein endothelial cells (HUVECs) inoculated with H9N2 virus and viral particle. HUVECs were inoculated
with H9N2 virus or viral particle at a multiplicity of infection (MOI) of 5, and then supernatants were collected at 6, 12, 24 and 36 h postinfection. IFN-α and IFN-β levels were
determined using enzyme-linked immunosorbent assay (ELISA). Values represent the means from three independent experiments plus standard deviations.
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α/β levels between experimental and control groups at each
time point.
CXCL10 mRNA and protein levels in HUVECs
Microarray analysis showed a signiﬁcant up-regulation of
CXCL10 gene expression induced by H9N2 virus and viral particles
at 24 h postinfection. We further validated the CXCL10 gene
expression at transcriptional level by qRT-PCR and at protein level
by ELISA, respectively. The result showed that HUVECs expressed
high levels of CXCL10 mRNA and protein after inoculation with
H9N2 viruses or viral particles (Fig. 7), exhibiting a similar pattern
of expression to those analyzed by microarray. As shown in Fig. 7A,
the CXCL10 mRNA expressions by qRT-PCR in HUVECs were
signiﬁcantly increased at 6, 12, 24 and 36 h postinfection com-
pared with control (P valueo0.01, t-test). And H9N2 virus infec-
tion induced more signiﬁcant up-regulation of CXCL10 compared
with viral particle inoculation at 6 h (Po0.05), 12 h (Po0.05),
24 h (Po0.01) and 36 h (Po0.01). In addition, HUVECs expressed
high levels of CXCL10 protein after inoculation with H9N2 viruses
or viral particles at 6, 12, 24 and 36 h postinfection compared with
control (P valueo0.01, t-test).
Discussion
The endothelium consists of a monolayer of endothelial cells that
line the entire vasculature. Its critical location allows endothelial cells
to serve regulatory functions in inﬂammation and immune response
(Duperray et al., 1995). Some viruses have been shown to directly
infect endothelial cells, and the activation/dysfunction of endothelial
cells due to virus infection may contribute to the development of
viral diseases (Valbuena and Walker, 2006). For example, dengue
virus (Dalrymple and Mackow, 2011), hantavirus (Geimonen et al.,
2002) and Ebola virus (Yang et al., 1998) have been evaluated for
their ability to replicate in the endothelial cells in vitro. Clinical and
in vivo experiments also indicate the endothelial infection for the
cytomegalovirus, Nipah virus and Crimean–Congo hemorrhagic fever
virus (Valbuena and Walker, 2006). Therefore, the endothelial cells
are targets of several infectious viruses and their interaction with
inﬂuenza viral infection deserves further investigation.
H5N1 inﬂuenza viruses were found to replicate in endothelial cell
lines and human lung microvascular endothelial cells (Viemann et al.,
2011; Zeng et al., 2012). It is still largely unknown whether H9N2
virus could infect endothelial cells and play a role of in H9N2 viral
pathogenesis. In the present study, we inoculated HUVECs with
H9N2 virus (Ck/HB/4/08), and measured the titers of viruses using
plaque assay. When HUVECs were treated with H9N2 viruses at a
different MOI for 24 h, viruses caused a dose-dependent increment
in titer levels. Then, we observed the kinetics of replication of H9N2
viruses at MOI of 5 and 0.2 at different times postinfection. The
productive replication of H9N2 viruses in HUVECs was detectable at
6 h (MOI of 5) or 36 h (MOI of 0.2) postinfection, and peaked at 36 h
(MOI of 5) or 48 h (MOI of 0.2) postinfection. In addition, a similar
growth kinetic pattern of H9N2 viruses was also observed at a MOI of
0.2 in MDCK cell, a standard model cell for inﬂuenza virus infection.
This suggests that HUVECs support the productive replication of
H9N2 virus in vitro. We have previously shown that H9N2 virus (Ck/
HB/4/08) used in this study are highly lethal for mice, producing 60%
mortality without prior adaptation after infection, although they had
low pathogenicity in chickens (Bi et al., 2010; Deng et al., 2010).
Infected mice showed severe respiratory syndrome, including pul-
monary hemorrhage (Deng et al., 2010). These ﬁndings indicate that
this H9N2 virus can cross species barriers and expand its host from
birds to mammals. It is important to point out that the basal lamina
of 100 nm in thickness is all that separating the respiratory epithe-
lium and vascular endothelial cells. It is highly possible that the
infection in respiratory epithelium, the primary target cell for
inﬂuenza viruses, can readily spread to vascular endothelial cells in
alveolar wall. The interaction between endothelial cells and inﬂuenza
viruses may contribute to the development of severe inﬂuenza
disease of animals and patients with viral infection. Further research
is warranted to elucidate whether H9N2 viruses can infect endothe-
lial cells in vivo and participate in local pathological processes.
The changes in gene expression observed using microarray
technology might provide some useful data for the interaction
between endothelial cells and inﬂuenza viruses. In the present
study, we observed global patterns of gene expression in HUVECs
at 24 h after inoculation with H9N2 viruses and viral particles.
Microarray analysis showed that H9N2 virus infection induced an
abundance of DEGs with over 2000 up-regulated genes and more
than 4000 down-regulated genes compared to controls, a typical
of transcriptional signature of viral infection. In contrast, H9N2
viral particles inoculation yielded only a small numbers of DEGs
with 177 up-regulated genes and 86 down-regulated genes,
indicating a non-infectious transcriptional signature. We observed
that H9N2 infection induced the expressional changes of the genes
encoding proteins associated with the structure and function of
Fig. 7. Analysis of expression of CXCL10 gene in human umbilical vein endothelial cells (HUVECs). HUVECs were inoculated with H9N2 virus or viral particle at a multiplicity
of infection (MOI) of 5, and cells or supernatants were collected at 6, 12, 24 and 36 h postinfection. Values represent the means from three independent experiments plus
standard deviations. (A) qRT-PCR analysis of the expression of CXCL10mRNA. The mRNA expressions of CXCL10 were normalized to those β-actin mRNA in the corresponding
samples. The fold changes in mRNA expression, determined using the comparative threshold cycle method, were relative to the control that equals one. (B) ELISA analysis of
the production of CXCL10. **, compared with control (P valueo0.01, t-test). #, compared with H9N2 virus group (P valueo0.05, t-test). ##, compared with H9N2 virus group
(P valueo0.01, t-test).
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endothelial cell itself, including apoptosis-related genes, adhesion
molecule genes and tight junction-related genes. A peculiar fea-
ture of inﬂuenza viruses is the induction of massive host cell death
(including apoptosis) in cell culture and animal models (Tripathi
et al., 2013). Endothelial apoptosis induced by inﬂuenza virus can
lead to pulmonary microvascular leak involved in lung injury
(Armstrong et al., 2012). Our GO function analysis showed 317
DEGs enriched in the regulation of apoptosis in HUVECs only
induced by H9N2 virus infection, but not by inactivated viral
particles. These data indicated that H9N2 virus infection may have
a profound effect on endothelial cell death, including apoptosis.
Apoptosis is executed by a subfamily of cysteine proteases known
as caspases. In mammalian cells, a major caspase activation path-
way is the cytochrome c-initiated pathway. In this pathway, a
variety of apoptotic stimuli cause cytochrome c release from
mitochondria, and this in turn induces a series of biochemical
reactions that result in caspase activation and subsequent cell
apoptosis (Jiang and Wang, 2004). We noticed that CYCS gene
exhibited 10-fold up-regulation in H9N2 virus-infected HUVECs.
Apparently, cytochrome c-mediated endothelial apoptosis deser-
ves the further evaluation in cell lines and animals infected by
H9N2 viruses.
Leukocyte adhesion and transendothelial migration are important
components of inﬂammatory vascular diseases in response to infec-
tion and tissue injury (Zhang et al., 2011). Adhesion molecules
expressed by activated endothelium mediate these processes. We
observed that H9N2 virus infection induced a differential expression
of some genes for adhesion molecules in HUVECs at a transcriptional
level. Adhesion molecule ICAM1 gene was signiﬁcantly down-reg-
ulated and the genes encoding ICAM4 and SELE were signiﬁcantly
up-regulated. Previous study showed that the function of ICAM4
appears to be restricted to erythrocytes (Bhalla et al., 2015; Hermand
et al., 2004; Ihanus et al., 2007). There has been very little research
on the effects of ICAM4 on host cell invasion. Further studies need to
be done to investigate whether the ICAM4 is involved in viral
infection in HUVECs. Alterations in tight junction proteins may lead
to the endothelial leak, which is thought to play a role in inﬂuenza
pathogenesis (Armstrong et al., 2012). We found that H9N2 virus
infection signiﬁcantly down-regulated the expression of genes
encoding tight junction proteins (OCLN, CLDN1, CLDN11 and
CLDN23) of HUVECs. Taken together, all the facts (the differential
expression of adhesion molecule genes, the down-regulation of tight
junction protein genes and the signiﬁcant changes in expressions of
hundreds of apoptosis-related genes) suggest that the structure and
function of endothelial cell itself might potentially be affected after
H9N2 virus infection, probably leading to endothelial dysfunction
and cell death.
The recruitment of innate immune cells into the lungs combined
with excessive proinﬂammatory cytokine and chemokine production
are hallmarks of inﬂuenza virus infection (La Gruta et al., 2007).
Chemokines are involved in the recruitment of circulating leukocytes
into the inﬂamed tissues, engendering the adaptive immune response
and contributing to the pathogenesis of a variety of diseases (Charo
and Ransohoff, 2006). Under our experimental conditions, we
observed high levels of the chemokine gene expression (including
CCL5, CXCL10 and CXCL11) in HUVECs 24 h after inoculation with
H9N2 viruses or viral particles, indicating that either H9N2 viral
particles alone or viral replication in cells led to the transcriptional
expressions of chemokine genes. Furthermore, H9N2 virus are more
potent than H9N2 particles in up-regulating chemokine gene expres-
sion, with over 100-fold up-regulation of CCL5 and CXCL10 gene
expression in cells with H9N2 virus infection. A recent study showed
that mice deﬁcient in CXCL10 or its receptor chemokine (C-X-C motif)
receptor 3 (CXCR3) have decreased lung injury severity and increased
survival in response to inﬂuenza virus (PR8/H1N1) infection (Ichikawa
et al., 2013). Considering that CXCL10 is important in lung injury, we
further validated the CXCL10 gene expression at transcriptional level
by qRT-PCR and at protein level by ELISA, respectively. The result
showed that HUVECs expressed high levels of the CXCL10 mRNA and
protein after inoculation with H9N2 viruses and viral particles,
exhibiting a similar pattern of expression to those analyzed by micr-
oarray. Our previous research indicated that H9N2 viruses (Ck/HB/4/
08) induced a typical acute lung injury with diffuse pneumonia and
alveolar damage (Deng et al., 2010). Whether chemokines mediate
lung injury induced by the H9N2 virus infection needs to be further
studied.
It is believed that the high fatality rate of avian inﬂuenza virus
infections is a consequence of an overactive inﬂammatory response
and the severity of infection is closely related with virus-induced
hypercytokinemia (“cytokine storm”) which is characterized by the
extreme production of pro-inﬂammatory cytokines (especially, TNF-
α, IL-1α, IL-1β, IL-6 and IL-8) (Tisoncik et al., 2012). In the present
study, we did not observe the signiﬁcant changes in proinﬂammatory
cytokine gene expression in HUVECs at 24 h after inoculation with
H9N2 viruses and viral particles.
The IFN system (mainly IFN-α and IFN-β) is a ﬁrst line of defense
against viral infections (Sen, 2001). It is well known that inﬂuenza
virus can infect respiratory epithelial cells and macrophages and
induce the production of type I IFNs (Pirhonen et al., 1999; Xing et al.,
2011). The expression of type I IFN genes is up-regulated in human
pulmonary microvascular endothelial cells after H5N1 virus infection
at 24 h postinfection (Zeng et al., 2012). Schmolke et al. (2009) have
demonstrated high expression of IFN-β at earlier time points (such as
8 h) following H5N1 virus infection of HUVECs. Under our experi-
mental conditions, we found that IFN gene expression proﬁles
induced by H9N2 virus and viral particles showed no signiﬁcant
change in transcriptional activity at 24 h postinfection. For validation
of IFN expression change at protein level, we quantiﬁed the IFN-α/β
using human IFN-α and IFN-β ELISA Kits. The results showed that
there were no signiﬁcant differences in the released IFN-α/β levels
between experimental and control groups at each time point,
exhibiting a similar pattern of expression to those analyzed by
microarray. Surprisingly, microarray data analysis revealed that the
most signiﬁcantly up-regulated genes were mainly ISGs in HUVECs
after inoculation with H9N2 viruses and viral particles, although
there were no signiﬁcant changes in the IFN mRNA and protein
levels. These up-regulated ISGs include those encoding IFIT family
proteins (IFIT1, IFIT2, IFIT3 and IFIT5), IFITM family proteins (IFITM1
and IFITM2) and OAS proteins (OAS1 and OAS2). ISG products take on
a number of diverse roles, and collectively, they are highly effective at
resisting and controlling pathogens (Schneider et al., 2014). It is
believed that IFIT genes are rapidly induced in many virus-infected
cells through IFN-dependent and -independent pathways (Diamond
and Farzan, 2013). Strong evidences indicated that this family of
related proteins inhibits viral infections through multiple mechan-
isms by suppressing translation initiation, binding uncapped or
incompletely capped viral RNA, and sequestering viral proteins or
RNA in the cytoplasm (Diamond and Farzan, 2013). IFITM proteins
are a family of small transmembrane proteins that are generally
induced by IFNs, but that are also expressed basally in several cell
types and lines. The primary role of IFITM proteins seems to be
antiviral, although other functions have been proposed (Diamond
and Farzan, 2013). The OAS proteins play an antiviral role by acting
with ribonuclease L and degrading viral RNA in the cytoplasm
(Iwasaki and Pillai, 2014). The high level of up-regulation of these
ISGs demonstrated in this study indicates that further research is
warranted on the roles of ISG-encoded proteins in the interaction
between H9N2 virus infection and endothelial cells. In addition, it is
noteworthy that H9N2 viral particles were more potent than H9N2
viruses in inducing ISG expression in transcriptional activity, in that
only 5 MOI of inactivated virions (that is, 5 viral particles were added
per cell) could cause over 100-fold up-regulation of IFIT1 gene. These
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results suggest that the induction of ISGs expressions depends
mainly on the interaction between viral particles and endothelial
cells, but less so on viral replication. Our data may implicate an
antiviral mechanism in endothelial cells. Since the basal lamina is the
only structure interposed between the respiratory epithelium and
the microvascular endothelial cells in alveolar wall, it is conceivable
that viral particles released by epithelial cells can readily spread to
endothelial cells during inﬂuenza virus infection. In vivo, viral
particles might stimulate endothelial cells to express high levels of
ISGs, even without inﬂuenza virus replication in endothelial cells.
Taken together, we speculate that an antiviral pathway may exist
unrelated to IFN when endothelial cells are stimulated by H9N2 viral
particles and virus infection. Although the precise mechanism of this
phenomenon is unknown, it is possible that the host recognition
mechanisms might involve recognition of viral glycoproteins and/or
signaling by host receptor and internalization machinery through
cytoplasmic pathways. Boehme et al. (2004) found that replication-
defective human cytomegalovirus could elicit ISG expression that is
likely mediated by cellular interactions with the envelope glycopro-
tein B. Further investigation needs to be done for revealing the
nature of overlaps, if any, between the viral receptors and the IFN-
independent pathways.
In comparison to a previously performed transcriptional proﬁle of
H5N1-infected HUVECs (Viemann et al., 2011), we detected similarly
high levels of ISG and chemokine gene expression in H9N2-infected
HUVECs. We noticed that H5N1 virus infection in HUVECs also
induced high levels of IFN gene expression (Viemann et al., 2011).
In contrast, H9N2 virus infection did not induce up-regulation of IFN
gene expression at 24 h postinfection. This might be an inﬂuenza
virus subtype-speciﬁc response in HUVECs. Apparently, further stu-
dies are necessary to go beyond our current results. For example,
DEGs revealed in microarray analysis need to be validated by qRT-
PCR. We know that different endothelial cells show the heterogeneity
in structure and function, in time and space, and in health and
disease. Since inﬂuenza virus mainly infects the respiratory system,
we will conduct further research on pulmonary microvascular
endothelial cells to conﬁrm our results with HUVECs. In addition,
our results in cell culture will need to be validated in vivo, where
viral infection may cause complex interactions among viruses, cells
and cytokines.
Conclusions
Our study showed that HUVECs support the productive replica-
tion of H9N2 virus (Ck/HB/4/08). Microarray analysis revealed that
both H9N2 virus infection and viral particles signiﬁcantly up-
regulated the transcriptional expression of ISGs and chemokine
genes in HUVECs. In addition, H9N2 virus infection signiﬁcantly
down-regulated the expression of genes encoding tight junction
proteins. These data will offer further insight into the interaction
between endothelial cells and H9N2 inﬂuenza viruses.
Materials and methods
Virus and virus inactivation
The H9N2 virus used in this study was A/Chicken/Hebei/4/2008
(H9N2) (Ck/HB/4/08). The complete genome sequences of the virus
are available from GenBank under accession numbers FJ499463–
FJ499470. The viruses were propagated in the allantoic cavities of 9-
day-old embryonated eggs from speciﬁc-pathogen-free (SPF) hens
for 48 to 60 h at 37 1C. Third-passage viruses (infectious allantoic
ﬂuid) were clariﬁed by centrifugation and stored at 70 1C. Virus
titers were determined by plaque assay.
To observe the interaction between H9N2 viral particles and
HUVECs, we created a replication-deﬁcient H9N2 virus (i.e., inacti-
vated H9N2 viral particles). For this, H9N2 viral culture supernatants
were incubated in 0.094% β-propionolactone (BPL; SERVA Electro-
phoresis, Heidelberg, Germany) at 4 1C for 9 h, followed by incuba-
tion at 37 1C for 2 h to facilitate the hydrolysis of BPL and inactivate
the viruses (Jonges et al., 2010). To validate whether viral replicative
capacity was completely destroyed, the supernatants were titrated
for viral infectivity with plaque assay. When viral plaque did not
form, the harvested inactivated viruses were stored at 70 1C until
further use. All researches with the virus were conducted under
biosafety level 2 containment conditions.
Plaque assay
To evaluate viral titers, the plaque assay on Madin–Darby
canine kidney (MDCK) cells was performed as described pre-
viously (Tobita et al., 1975). In brief, MDCK cells (ATCC, Manassas,
VA, USA) were grown in Dulbecco's modiﬁed Eagle's medium
(DMEM; Gibco, Carlsbad, CA, USA) with 10% fetal bovine serum
(FBS; Gibco, Carlsbad, CA, USA) and seeded into six-well plates.
Conﬂuent monolayers were washed with phosphate buffered
saline (PBS) and infected with serial 10-fold dilutions of viruses
or cell culture supernatants. The inoculum was aspirated after
incubation for 1 h and the remaining cells were washed with PBS.
An overlay consisting of a mixture of 1.6% agarose (Lonza, Allen-
dale, NJ, USA) and double-strength DMEM with 2 μg/mL N-p-
tosyl-L-phenylalanine chloromethyl ketone (TPCK)-treated trypsin
(Worthington, Freehold, NJ, USA) was added to the above cells and
incubated at 37 1C for 72 h. Plaques were stained with 0.1% crystal
violet and counted.
Cells and virus infection
Cells: HUVECs (CRL-1730) (purchased from ATCC, Manassas,
VA, USA) were cultured in DMEM supplemented with 10% FBS and
endothelial cell growth supplement (ECGS; Sciencell, Carlsbad, CA,
USA) at 37 1C in a 5% CO2 incubator. The cells used in passages 5–8
were seeded into six-well plates at 5105/well and cultured for
24 h before virus infection experiments.
Virus infection: The growth of low pathogenic avian inﬂuenza
virus (including H9N2 virus) in many cell lines requires the
addition of trypsin (as an exogenous protease) to culture medium
to ensure viral hemagglutination (HA) cleavage and multicycle
infection. The replication kinetics of the H9N2 viruses was mea-
sured in the absence or presence of trypsin. In the absence of
trypsin, H9N2 virus did not infect the HUVECs as detected by PFU.
Therefore, the trypsin was added to the culture medium in all
experiments on H9N2 virus infection. To assess H9N2 virus
infection, monolayer of HUVECs were washed with PBS, inoculated
with virus at different multiplicity of infection (MOI) and then
incubated for 1 h. Cells were washed with PBS and added with
DMEM supplemented with 0.2% bovine serum albumin (BSA;
Gibco, Carlsbad, CA, USA) and 0.25 μg/mL of TPCK-treated trypsin.
Cells were collected at multiple time points after inoculation for
microarray study, and the titers of viruses in the supernatant were
measured using plaque-forming units (PFUs).
HUVECs were divided into three groups: H9N2 virus group
(infection of virus at a MOI of 5), viral particle group (inoculation
of inactivated virus at a MOI of 5) and control group (inoculation of
equivalent amounts of virus-free media). The control group
medium processed with the same condition as the viral particle
group and H9N2 virus group. At 24 h postinfection, RNA in each
sample of three groups (two samples per group) was extracted,
and then the global patterns of gene expression in HUVECs were
detected using microarrays.
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RNA extraction, microarray hybridization and data analysis
Total RNA was isolated using Trizol reagent (Invitrogen, Carls-
bad, CA, USA) from the three groups. RNA was puriﬁed using the
Qiagen RNeasy Mini Kit according to the manufactures' instruc-
tions. The RNA was quantiﬁed by ultraviolet Spectrophotometer
(NanoDrop Technologies, Rockland, DE, USA) and its quality was
determined by formaldehyde agarose gel electrophoresis.
An aliquot of 200 ng of total RNA from each group of sample
was used to synthesize double-stranded cDNA, which was subse-
quently transcribed into biotinylated aRNA using MessageAmp
Premier RNA Ampliﬁcation Kit (Life Technologies Corporation,
Carlsbad, CA USA). Biotinylated aRNA fragments were hybridized
to Affymetrix Human Genome U133 Plus 2.0 Gene Array chip
(Affymetrix, Santa Clara, CA, USA) containing over 38,500 human
genes according to instruction of the supplier. Fluorescent signals
were detected by the Affymetrix GeneChip scanner 3000 (Affyme-
trix, Santa Clara, CA, USA). Raw data (.CEL Intensity ﬁles) were
extracted from scanned images using the Affymetrix GeneChip
Command Console (AGCC) software. The raw data were normal-
ized and summarized using the Affymetrix Microarray Suite 5.0
(MAS5) and Robust Multi-array Average (RMA) algorithm.
To validate the microarray data and to minimize false readings,
two samples per group were used. In a comparison analysis
between experimental and control groups, the genes with 2.0 folds
up/down-regulation and P valueo0.05 (Student's t-test) were
considered as differentially expressed genes (DEGs). When genes
were represented by more than one probe set, only one transcript
was considered to avoid potential bias. For functional classiﬁcation
of the genes, the DEGs were mapped to Gene Ontology (GO) terms
and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
based on the probe set ID, using DAVID (http://david.abcc.ncifcrf.
gov/) platform (Dennis et al., 2003). GO terms and KEGG pathways
with P values (Fisher's exact test) less than 0.05 were considered
statistically signiﬁcant. To detect gene groupings that manifest
similar expression patterns between H9N2 viruses and viral
particles, these transcripts were hierarchically clustered based on
the average linkage distance measure using Gene Cluster 3.0 soft-
ware. The gene expression cluster was visualized with Java Tree
View (de Hoon et al., 2004).
The information regarding our data was submitted to the Gene
Expression Omnibus, the accession number is GSE59226.
Determination of cell viability by trypan blue dye exclusion test
To determine cell viability, the trypan blue-exclusion method
was used. Brieﬂy, at multiple time points after infection, super-
natants were removed from infected monolayers. The monolayers
were trypsinized and combined with the supernatant. After
centrifugation, the supernatant was discarded, and the cell pellet
was resuspended and incubated with 0.1% trypan blue (Gibco,
Carlsbad, CA, USA) for 5 min at room temperature. The percentage
of viable cells was quantiﬁed using a hemacytometer and a light
microscope by counting a minimum of 200 cells. All experiments
were performed in triplicate.
ELISA assays for IFN-α/β and CXCL10
Cell culture supernatant samples were collected from experi-
mental and control groups at various time points postinfection.
IFN-α/β and chemokine (C-X-C motif) ligand 10 (CXCL10) levels in
these samples were determined by enzyme-linked immunosor-
bent assay (ELISA) kit according to the manufacturer's instructions
(Mlbio, Shanghai, China).
Quantitative real-time PCR for CXCL10 gene expression
Total RNA was isolated from cultured cells in each group at 6, 12,
24 and 36 h after treatment. cDNA was synthesized from 1 mg total
RNA using a PrimeScript RT reagent Kit with gDNA Eraser (Takara,
Ohtsu, Japan). Quantitative real-time PCR (qRT-PCR) was performed
using the Power SYBR Green Master Mix (Applied Biosystems, Foster
City, CA, USA). Reactions were carried out on an ABI 7500 Real Time
PCR machine (Applied Biosystems, Foster City, CA, USA). Gene
expression was normalized to the endogenous housekeeping control
gene β-actin. All samples were analyzed in triplicate, and relative
quantiﬁcation was calculated by the comparative threshold cycle
method as described (Livak and Schmittgen, 2001).
Statistical analysis
Unless otherwise indicated, statistical signiﬁcance of differ-
ences were determined through the use of the Student's t test or
one-way analysis of variance (ANOVA) as indicated in the ﬁgure
legend or text. All the statistical tests were performed using Excel
software (Microsoft, Redmond, WA, USA). P values less than 0.05
were considered statistically signiﬁcant.
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